Promoting growth
Long-term partner for start-ups
We have already accompanied over 100 start-up projects. We usually acquire a minority share in the resulting companies.
We continue to support our portfolio companies on their growth trajectory and manage our shares as profitably as possible until exit – or, in the case of floatation or takeovers by listed companies, beyond.
We distribute most of our revenues from the sale of equity and shares to the LifeScience Foundation, which in turn makes them available to its endowing institutes as research grants
Current shareholdings
Former shareholdings
Activaero GmbH
Inhalation technology and aerosol medicine - Acquisition by Vectura Group in March 2014
Bioregeneration GmbH
Development of products based on Xellulin®
BITZ GmbH
IT solutions for scientific work in biology, biotechnology and health research
Clueda AG
Intelligent big data solutions for semantic extcraction of knowledge - Acquisition by Baader Bank in June 2015
Dualis MedTech GmbH
Fully implantable pulsatile ventricular assist systems with wireless power and data transfer
eADMET GmbH
Web-based solutions for data storage, integration, interpretation and modelling for physico-chemical and ADMET predictions
Encepharm GmbH
Preclinical contract research in the field of mental illness
Genomatix GmbH
Bioinformatics for functional genome analysis
NanoRepro GmbH
Development, manufacturing and marketing of rapid diagnostics (self diagnostics) for domestic use
Protectimmun GmbH
Development of vaccines and drugs for allergies and chronic inflammatory diseases
SurgVision B.V.
Development of optoacoustic imaging technology for use in preclinical and clinical applications - Acquisition by Bracco in October 2017
Trianta Immunotherapies GmbH
T-cell focused therapies for treatment of cancer - Acquisition by Medigene in January 2014
TRION Pharma GmbH
Development of trifuncional antibodies for treatment of cancer - Acquisition by Fresenius Biotech
Vakzine Projekt Management GmbH
Consulting and services for the development of vaccines and biopharmaceuticals from the lab to clinical trials
WBC Drug Delivery Technologies
Liposome-based drug delivery platform for improved application of therapeutics - Acquisition by Klaria Pharma Holding AB in September 2019
Zellkraftwerk GmbH
Development and marketing of high content cytometry devices and tests for diagnosis of infectious diseases based on two platform technologies - Acquisition by Canopy in April 2019